Wuhan YZY Biopharma
As of the edition of 20 October 2026, Wuhan YZY Biopharma runs 4 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Status not established | 3 |
| Total | 4 |
Where its trials are
- Cancer: 5 trials led
- Blood and lymph: 1 trials led
- Heart and blood vessels: 1 trials led